Leukemias induced by altered TRK-signaling are sensitive to mTOR inhibitors in preclinical models.
about
Leukemias induced by altered TRK-signaling are sensitive to mTOR inhibitors in preclinical models.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Leukemias induced by altered T ...... ibitors in preclinical models.
@en
Leukemias induced by altered T ...... ibitors in preclinical models.
@nl
type
label
Leukemias induced by altered T ...... ibitors in preclinical models.
@en
Leukemias induced by altered T ...... ibitors in preclinical models.
@nl
prefLabel
Leukemias induced by altered T ...... ibitors in preclinical models.
@en
Leukemias induced by altered T ...... ibitors in preclinical models.
@nl
P2093
P2860
P1433
P1476
Leukemias induced by altered T ...... hibitors in preclinical models
@en
P2093
Adrian Schwarzer
Arnold Ganser
Christopher Baum
Johann Meyer
Mathias Rhein
Volkhard Kaever
Zhixiong Li
P2860
P304
P356
10.1007/S00277-010-1065-3
P577
2010-09-07T00:00:00Z